Nis Register Study Comparing Seroquel and Seroquel Prolong

AstraZeneca

Status: Completed

Conditions: Comparing Hospitalisation Time With Seroquel and Seroquel Prolong

Study type: Observational

Funder types: Industry

Identifiers

NCT00965536

NIS-NFI-SER-2009/1

Details and patient eligibility

About

The general aim of this non interventional study is to clarify what are the current clinical treatment practices of Quetiapine Immediate Release and Quetiapine Extended Release. The primary objectives of the study are:1.To collect information on the used Quetiapine Immediate Release or Quetiapine Extended Release medication 2.To collect information on duration and number of hospitalisation days 3.Change of GAF points

Enrollment: 200 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Medication: Seroquel or Seroquel Prolong
• Diagnosis: F20-F29 or F30-F31 (ICD-10)
• In-patient

Exclusion criteria

• None

Trial design

200 participants in 2 patient groups

1

Description:

Seroquel

2

Description:

Seroquel Prolong